Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer Liaison Group.
Date: October 25, 2006.
Time: 7:30 a.m. to 6 p.m.
Agenda: (1) Meeting with NCI Acting Director; (2) Updates on NCI Programs; (3) Update on NCI Budget and Legislation; Report from NCI Listens and Learns Working Group and DCLG Summit Working Group; (4) Public Comment; (5) Action Items and Conclusion.
Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Barbara Guest, Executive Secretary, Office of Liaison Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 2202, Rockville, MD 20892-8324, 301-496-0307, firstname.lastname@example.org.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda and any additional information for the meeting will be posted when available.Start Signature
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS).
Dated: August 8, 2006.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-6963 Filed 8-16-06; 8:45 am]
BILLING CODE 4140-01-M